Burden of malaria in early pregnancy: A neglected problem?

Clinical Infectious Diseases

Volumn 60, Issue 4, 2015, Pages 598-604

  Huynh, Bich Tram ^a,b   Cottrell, Gilles ^a,b   Cot, Michel ^a,b   Briand, Valérie ^a,b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Africa; malaria; pregnancy complication; prevention; time factors

Indexed keywords

ANTIMALARIAL AGENT; MALARIA VACCINE;

ADOLESCENT; ANEMIA; COST OF ILLNESS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; MALARIA; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

ADOLESCENT; ANEMIA; ANTIMALARIALS; COST OF ILLNESS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALARIA; MALARIA VACCINES; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, FIRST;

EID: 84922340119     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu848     Document Type: Review

References (43)

1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med 2010; 7:e1000221
2. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61:1005-16
3. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104
4. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 2007; 7:105-17
5. World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African Region. Geneva, Switzerland: WHO, 2004
6. World Health Organization. Updated WHO policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva, Switzerland: WHO, 2012
7. Cottrell G, Mary JY, Barro D, Cot M. The importance of the period of malarial infection during pregnancy on birth weight in tropical Africa. Am J Trop Med Hyg 2007; 76:849-54
8. Griffin JB, Lokomba V, Landis SH, et al. Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study. Malar J 2012; 11:319
9. Valea I, Tinto H, Drabo MK, et al. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J 2012; 11:71
10. De Beaudrap P, Turyakira E, White LJ, et al. Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malar J 2013; 12:139
11. Huynh BT, Fievet N, Gbaguidi G, et al. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg 2011; 85:214-20
12. Kalilani-Phiri L, Thesing PC, Nyirenda OM, et al. Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes. PLoS One 2013; 8:e74643
13. Doritchamou J, Bertin G, Moussiliou A, et al. First-trimester Plasmodium falciparum infections display a typical "placental" phenotype. J Infect Dis 2012; 206:1911-9
14. Umbers AJ, Aitken EH, Rogerson SJ. Malaria in pregnancy: small babies, big problem. Trends Parasitol 2011; 27:168-75
15. Xiong X, Buekens P, Alexander S, Demianczuk N, Wollast E. Anemia during pregnancy and birth outcome: a meta-Analysis. Am J Perinatol 2000; 17:137-46
16. Ouedraogo S, Koura GK, Bodeau-Livinec F, Accrombessi MM, Massougbodji A, Cot M. Maternal anemia in pregnancy: assessing the effect of routine preventive measures in a malaria-endemic area. Am J Trop Med Hyg 2013; 88:292-300
17. Muehlenbachs A, Mutabingwa TK, Edmonds S, Fried M, Duffy PE. Hypertension and maternal-fetal conflict during placental malaria. PLoS Med 2006; 3:e446
18. Ndao CT, Dumont A, Fievet N, Doucoure S, Gaye A, Lehesran JY. Placental malarial infection as a risk factor for hypertensive disorders during pregnancy in Africa: a case-control study in an urban area of Senegal, West Africa. Am J Epidemiol 2009; 170:847-53
19. Walker PG, Griffin JT, Cairns M, et al. A model of parity-dependent immunity to placental malaria. Nat Commun 2013; 4:1609
20. Kinney MV, Kerber KJ, Black RE, et al. Sub-Saharan Africa's mothers, newborns, and children: where and why do they die?. PLoS Med 2010; 7: e1000294
21. Pell C, Menaca A, Were F, et al. Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One 2013; 8:e53747
22. Hill J, Kayentao K, Toure M, et al. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey. PLoS One 2014; 9:e92102
23. Finlayson K, Downe S. Why do women not use antenatal services in low- and middle-income countries?. A meta-synthesis of qualitative studies. PLoS Med 2013; 10:e1001373
24. Gies S, Coulibaly SO, Ky C, Ouattara FT, Brabin BJ, D'Alessandro U. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg 2009; 80:460-9
25. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D. Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review. PLoS Med 2012; 9: e1001244
26. Rijken MJ, Gilder ME, Thwin MM, et al. Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study. PLoS One 2012; 7:e34018
27. Mbonye AK, Magnussen P, Bygbjerg IB. Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda. Trop Med Int Health 2007; 12:519-31
28. Gies S, Coulibaly SO, Ouattara FT, Ky C, Brabin BJ, D'Alessandro U. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso. Malar J 2008; 7:180
29. Msyamboza KP, Savage EJ, Kazembe PN, et al. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health 2009; 14:183-9
30. Ndyomugyenyi R, Tukesiga E, Katamanywa J. Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities. Trans R Soc Trop Med Hyg 2009; 103:1221-8
31. Okeibunor JC, Orji BC, BriegerW, et al. Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State, Nigeria. Malar J 2011; 10:227
32. Willey BA, Paintain LS, Mangham L, Car J, Schellenberg JA. Strategies for delivering insecticide-treated nets at scale for malaria control: a systematic review. Bull World Health Organ 2012; 90:672-84E
33. Kurth F, Belard S, Mombo-Ngoma G, et al. Adolescence as risk factor for adverse pregnancy outcome in Central Africa-A cross-sectional study. PLoS One 2010; 5:e14367
34. Yukich JO, Lengeler C, Tediosi F, et al. Costs and consequences of largescale vector control for malaria. Malar J 2008; 7:258
35. Briand V, Bottero J, Noel H, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis 2009; 200:991-1001
36. González R, Mombo-Ngoma G, Ouédraogo S, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIVnegative women: a multicentre randomized controlled trial. PLoS Med 2014; doi:10.1371/journal.pmed.1001733
37. Schlagenhauf P, BlumentalsWA, Suter P, et al. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis 2012; 54:e124-31
38. World Health Organization, Malaria Policy Advisory Committee. Conclusions and recommendations of September 2013 meeting. Malar J 2013; 12:456
39. van Eijk AM, Terlouw DJ. Azithromycin for treating uncomplicated malaria. Cochrane Database Syst Rev 2011; CD006688
40. Chandra RS, Orazem J, Ubben D, Duparc S, Robbins J, Vandenbroucke P. Creative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa. Malar J 2013; 12:122
41. World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva, Switzerland: WHO, 2010
42. McGready R, Lee SJ, Wiladphaingern J, et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 2012; 12: 388-96
43. Adegnika AA, Verweij JJ, Agnandji ST, et al. Microscopic and submicroscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg 2006; 75:798-803